{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:18:14Z","timestamp":1648775894855},"reference-count":106,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.arteri.2015.01.006","type":"journal-article","created":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T04:30:29Z","timestamp":1426134629000},"page":"287-300","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevenci\u00f3n secundaria del ictus isqu\u00e9mico no cardioemb\u00f3lico"],"prefix":"10.1016","volume":"27","author":[{"given":"Pedro","family":"Armario","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Soler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pere","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2015.01.006_bib0535","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1474-4422(09)70023-7","article-title":"Global variation in stroke burden and mortality: Estimates from monitoring, surveillance, and modelling","volume":"8","author":"Johnston","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.arteri.2015.01.006_bib0540","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0212-8241(08)75976-0","article-title":"Hipertensi\u00f3n arterial e ictus: Encadenados y Sin perd\u00f3n","volume":"25","author":"Sierra","year":"2008","journal-title":"Hipertensi\u00f3n"},{"key":"10.1016\/j.arteri.2015.01.006_bib0545","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack. A guideline for Healthcare Professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.arteri.2015.01.006_bib0550","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1212\/WNL.0b013e3181cff776","article-title":"Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients","volume":"74","author":"Feng","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.arteri.2015.01.006_bib0555","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1161\/STROKEAHA.110.602615","article-title":"Risk and cumulative risk of stroke recurrence. A systematic review and meta-analysis","volume":"42","author":"Mohan","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.arteri.2015.01.006_bib0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.medcli.2010.10.027","article-title":"Infartos cerebrales recurrentes: estudio de 605 pacientes","volume":"137","author":"Arboix","year":"2011","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.arteri.2015.01.006_bib0565","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(13)70255-2","article-title":"Secondary stroke prevention","volume":"13","author":"Hankey","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.arteri.2015.01.006_bib0570","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0140-6736(11)60516-3","article-title":"Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischemic stroke","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2015.01.006_bib0575","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1056\/NEJMcp1107281","article-title":"Secondary prevention after ischemic stroke or transient ischemic attack","volume":"366","author":"Davis","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arteri.2015.01.006_bib0580","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.01.014","article-title":"Therapeutic interventions in risk factor control for secondary prevention of stroke","volume":"18","author":"Alvarez-Sabin","year":"2009","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.arteri.2015.01.006_bib0585","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.medcli.2010.04.035","article-title":"Control de los factores de riesgo cardiovascular en pacientes con ictus atendidos en Atenci\u00f3n Primaria en Espa\u00f1a. Estudio ICTUSCARE","volume":"136","author":"Abell\u00e1n Alem\u00e1n","year":"2011","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.arteri.2015.01.006_bib0590","article-title":"Control of main risk factors after ischaemic stroke across Europe: Data from the stroke-specific module of the EUROASPIRE III survey","author":"Heuschmann","year":"2014","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.arteri.2015.01.006_bib0595","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","article-title":"Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised during trials in their epidemiological context","volume":"335","author":"Collins","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2015.01.006_bib0600","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0140-6736(90)90878-9","article-title":"Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias","volume":"335","author":"MacMahon","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2015.01.006_bib0605","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.arteri.2015.01.006_bib0610","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","article-title":"Prognostic factor significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension","volume":"375","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2015.01.006_bib0615","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/STROKEAHA.110.611566","article-title":"Effects of dose and combination of antihypertensives on interindividual blood pressure variability. A systematic review","volume":"42","author":"Webb","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.arteri.2015.01.006_bib0620","first-page":"570","article-title":"Prevalencia de hypertension arterial en L\u2019Hospitalet de LLobregat. Evoluci\u00f3n de la tasa de control entre 1981 y 1987","volume":"94","author":"Armario Garc\u00eda","year":"1990","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.arteri.2015.01.006_bib0625","first-page":"300","article-title":"Ecological association between hypertension and stroke in Catalonia (Spain): Development and use of an ecological regression model","volume":"4","author":"Tresserras","year":"1990","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.arteri.2015.01.006_bib0630","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/jama.289.18.2363","article-title":"Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States","volume":"289","author":"Wolf-Maier","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.arteri.2015.01.006_bib0635","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/01.HYP.0000259104.60878.43","article-title":"Differences in blood pressure control and stroke mortality across Spain. The Prevenci\u00f3n de Riesgo de Ictus (PREV-ICTUS) Study","volume":"49","author":"Red\u00f3n","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.arteri.2015.01.006_bib0640","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.medcli.2009.02.037","article-title":"Gu\u00eda de pr\u00e1ctica cl\u00ednica sobre prevenci\u00f3n primaria y secundaria del ictus","volume":"133","author":"Rigau Comas","year":"2009","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.arteri.2015.01.006_bib0645","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1161\/01.STR.0000092488.40085.15","article-title":"Blood pressure reduction and secondary prevention of stroke and other vascular events: A systematic review","volume":"34","author":"Rashid","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.arteri.2015.01.006_bib0650","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1755-7682-2-30","article-title":"Blood pressyre lowering treatment for preventing stroke recurrence: A systematic review and meta-analysis","volume":"2","author":"Lahkan","year":"2009","journal-title":"Int Arch Med"},{"key":"10.1016\/j.arteri.2015.01.006_bib0655","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/01.STR.24.4.543","article-title":"Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke","volume":"24","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.arteri.2015.01.006_bib0660","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000107813","article-title":"Atenolol in secondary prevention after stroke","volume":"5","author":"Eriksson","year":"1995","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.arteri.2015.01.006_bib0665","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/hr.2009.139","article-title":"Blood pressure reduction for the secondary prevention of stroke: A Chinese trial and a systematic review of the literature","volume":"32","author":"Liu","year":"2009","journal-title":"Hypertension Res"},{"key":"10.1016\/j.arteri.2015.01.006_bib0670","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arteri.2015.01.006_bib0675","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischemic attack","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2015.01.006_bib0680","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.hjh.0000226212.34055.86","article-title":"Lower target blood pressure are safe and effective for the prevention of recurrent stroke; the PROGRESS trial","volume":"24","author":"Arima","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.arteri.2015.01.006_bib0685","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.STR.0000166048.35740.a9","article-title":"Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention. Principal results of a prospective randomized controlled study (MOSES)","volume":"36","author":"Schrader","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.arteri.2015.01.006_bib0690","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","article-title":"Telmisartan to prevent recurrent stroke and cardiovascular events","volume":"359","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arteri.2015.01.006_bib0695","first-page":"CD007890","article-title":"Beta-blockers for preventing stroke recurrence","volume":"5","author":"De Lima","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arteri.2015.01.006_bib0700","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2174\/156802609789869592","article-title":"Blood pressure as a therapeutic target in stroke","volume":"9","author":"Armario","year":"2009","journal-title":"Curr Topics Med Chemistry"},{"key":"10.1016\/j.arteri.2015.01.006_bib0705","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jash.2014.05.002","article-title":"Lowering blood pressure to prevent stroke recurrence: A systematic review of long-term randomized trials","volume":"8","author":"Feldstein","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.arteri.2015.01.006_bib0710","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC Guidlines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.arteri.2015.01.006_bib0715","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","article-title":"Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Jauch","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.arteri.2015.01.006_bib0720","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1161\/STROKEAHA.114.003666","article-title":"Lowering of blood pressure for recurrent stroke prevention","volume":"45","author":"Boan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.arteri.2015.01.006_bib0725","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.22496","article-title":"Does achieving an intensive versus usual blood pressure level prevent stroke","volume":"71","author":"Lee","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.arteri.2015.01.006_bib0730","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent lacunar styroke: The SPS3 randomised trial","volume":"382","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2015.01.006_bib0735","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/HJH.0000000000000098","article-title":"Lower systolic blood pressure is associated with poorer survival in long-term survivors of stroke","volume":"32","author":"Kim","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.arteri.2015.01.006_bib0740","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.113.02503","article-title":"Optimun blood pressure target after lacunar stroke","volume":"63","author":"Hankey","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.arteri.2015.01.006_bib0745","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/HYPERTENSIONAHA.113.02529","article-title":"Optimum blood pressure target after lacunar stroke","volume":"63","author":"Schiffrin","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.arteri.2015.01.006_bib0750","first-page":"22","article-title":"Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohorte study","volume":"333","author":"Ebrahim","year":"2006","journal-title":"published correction appears in BMJ."},{"key":"10.1016\/j.arteri.2015.01.006_bib0755","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM198904063201405","article-title":"Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial","volume":"320","author":"Iso","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arteri.2015.01.006_bib0760","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/jama.2008.621","article-title":"Nonfasting triglycerides and risk of ischemic stroke in the general population","volume":"300","author":"Freiberg","year":"2008","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2015.01.006_bib0765","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2015.01.006_bib0770","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1161\/01.STR.0000147965.52712.fa","article-title":"Statins in stroke prevention and carotid atherosclerosis: Systematic review and up-to-date meta-analysis","volume":"35","author":"Amarenco","year":"2004","journal-title":"Stroke."},{"key":"10.1016\/j.arteri.2015.01.006_bib0775","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/STROKEAHA.107.493106","article-title":"Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARC) trial","volume":"38","author":"Amarenco","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.arteri.2015.01.006_bib0780","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1212\/01.wnl.0000296277.63350.77","article-title":"Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study","volume":"70","author":"Goldstein","year":"2008","journal-title":"Neurology."},{"key":"10.1016\/j.arteri.2015.01.006_bib0785","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","article-title":"Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Furie","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.arteri.2015.01.006_bib0790","first-page":"227","article-title":"for the Coordinating Committee on the National Cholesterol Education Program","volume":"110","author":"Grundy","year":"2004","journal-title":"Implications of recent trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation."},{"issue":"25 Pt B","key":"10.1016\/j.arteri.2015.01.006_bib0795","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arteri.2015.01.006_bib0800","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ecl.2008.11.007","article-title":"Lowering low-density lipoprotein cholesterol: Statins, ezetimibe, bile acid sequestrants, and combinations: Comparative efficacy and safety","volume":"38","author":"Hou","year":"2009","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.arteri.2015.01.006_bib0805","series-title":"National clinical guideline for stroke","year":"2008"},{"key":"10.1016\/j.arteri.2015.01.006_bib0810","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice","volume":"33","author":"Chapman","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.arteri.2015.01.006_bib0815","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: Evidence and guidance for Management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.arteri.2015.01.006_bib0820","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0214-9168(14)70025-7","article-title":"Indicaciones para la combinai\u00f3n de pravasttina y fenofibrato seg\u00fa n el nivel de reisgo cardioovascular. Situaciones clinicas comunes","volume":"26","author":"Pint\u00f3","year":"2014","journal-title":"Clin Invest Arterioscler"},{"issue":"38-40","key":"10.1016\/j.arteri.2015.01.006_bib0825","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.arteri.2013.11.007","article-title":"Dec\u00e1logo de recomendaciones clinicas en dislipemia aterog\u00e9nica","volume":"26","author":"Pedro-Botet","year":"2014","journal-title":"Clin Invest Arterioscler"},{"key":"10.1016\/j.arteri.2015.01.006_bib0830","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jacc.2008.10.024","article-title":"Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk","volume":"53","author":"Robinson","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arteri.2015.01.006_bib0835","unstructured":"Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GY, Manning WJ. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8 th edition)."},{"key":"10.1016\/j.arteri.2015.01.006_bib0840","doi-asserted-by":"crossref","first-page":"483S","DOI":"10.1378\/chest.126.3_suppl.483S","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Alberts","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.arteri.2015.01.006_bib0845","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1001\/archinte.159.11.1248","article-title":"A meta-regression analysis of the dose-response effect of aspirin on stroke","volume":"159","author":"Johnson","year":"1999","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.arteri.2015.01.006_bib0850","doi-asserted-by":"crossref","unstructured":"Antitrhombotix Trialists\u2019 Collaboratyion. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.","DOI":"10.1136\/bmj.324.7329.71"},{"key":"10.1016\/j.arteri.2015.01.006_bib0855","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM199110313251801","article-title":"A comparison of two doses of aspirin (30mg vs. 283mg a day) in patients after a transient ischemic attack or minor ischemic stroke","volume":"325","year":"1991","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2015.01.006_bib0860","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(91)92233-R","article-title":"Swedish Aspirin Low-dose Trial (SALT) of 75mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events","volume":"338","year":"1991","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2015.01.006_bib0865","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1001\/archinte.162.19.2197","article-title":"Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events","volume":"162","author":"Weisman","year":"2002","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.arteri.2015.01.006_bib0870","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2015.01.006_bib0875","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jama.280.22.1930","article-title":"Aspirin and risk of hemorrhagic stroke: A meta-analysis of randomized controlled trials","volume":"280","author":"He","year":"1998","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2015.01.006_bib0880","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/107424840501000302","article-title":"Review of antiplatelet therapy in secondary prevention of cerebrovascular events: A need for direct comparisons between antiplatelet agents","volume":"10","author":"Jamieson","year":"2005","journal-title":"J Cardiovasc Pharmacol Ther."},{"key":"10.1016\/j.arteri.2015.01.006_bib0885","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.289.22.2947","article-title":"Aspirin and ticlopidine for prevention of recurrent stroke in black patients","volume":"289","author":"Gorelick","year":"2003","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2015.01.006_bib0890","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","article-title":"A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients","volume":"321","author":"Hass","year":"1989","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2015.01.006_bib0895","first-page":"5","article-title":"The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke","volume":"121","author":"Gent","year":"1989","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2015.01.006_bib0900","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extendedrelease dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2015.01.006_bib0905","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebocontrolled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2015.01.006_bib0910","doi-asserted-by":"crossref","unstructured":"ESPRIT Study Group, K\u00a1Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerberal ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006;367:1665-73.","DOI":"10.1016\/S0140-6736(06)68734-5"},{"key":"10.1016\/j.arteri.2015.01.006_bib0915","first-page":"1351","article-title":"The European Stroke Prevention Study: Principal endpoints","volume":"2","year":"1987","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2015.01.006_bib0920","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2: Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.arteri.2015.01.006_bib0925","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.STR.0000063141.24491.50","article-title":"Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: The TACIP study: A randomized, double-blind, multicenter trial","volume":"34","author":"Matias-Guiu","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.arteri.2015.01.006_bib0930","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/jcbfm.2012.108","article-title":"Next-generation antithrombotics in ischemic stroke: Preclinical perspective on \u2018bleeding-free antithrombosis\u2019","volume":"32","author":"Kraft P1","year":"2012","journal-title":"J Cereb Blood Flow Metab."},{"key":"10.1016\/j.arteri.2015.01.006_bib0935","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arteri.2015.01.006_bib0940","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2337\/diacare.22.7.1077","article-title":"Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke","volume":"22","author":"Folsom","year":"1999","journal-title":"Diabetes Care."},{"key":"10.1016\/j.arteri.2015.01.006_bib0945","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/STROKEAHA.111.639922","article-title":"Obesity: A stubbornly obvious target for stroke prevention","volume":"44","author":"Kernan","year":"2013","journal-title":"Stroke."},{"key":"10.1016\/j.arteri.2015.01.006_bib0950","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/STROKEAHA.110.593434","article-title":"Association between obesity and mortality after acute first-ever stroke: The obesity-stroke paradox","volume":"42","author":"Vemmos","year":"2011","journal-title":"Stroke."},{"key":"10.1016\/j.arteri.2015.01.006_bib0955","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1161\/str.36.9.1835","article-title":"Alcohol and stroke an epidemiological labyrinth","volume":"36","author":"Klatsky","year":"2005","journal-title":"Stroke."},{"key":"10.1016\/j.arteri.2015.01.006_bib0960","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1161\/01.CIR.96.9.3243","article-title":"Cigarette smoking, cardiovascular disease, and stroke: A statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction","volume":"96","author":"Ockene","year":"1997","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2015.01.006_bib0965","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ypmed.2005.11.014","article-title":"Smoking predicts long-term mortality in stroke: The European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study","volume":"42","author":"Myint","year":"2006","journal-title":"Prev Med."},{"key":"10.1016\/j.arteri.2015.01.006_bib0970","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199108153250701","article-title":"Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arteri.2015.01.006_bib0975","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(97)09292-1","article-title":"European Carotid Surgery Trial (ECST Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC)","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2015.01.006_bib0980","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(98)11415-0","article-title":"Prediction of benefit from carotid endarterectomy in individual patients: A risk-modelling study","volume":"353","author":"Rothwell","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2015.01.006_bib0985","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0140-6736(06)69122-8","article-title":"Thirty day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: A randomised non-inferiority trial","volume":"368","author":"Ringleb","year":"2006","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2015.01.006_bib0990","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(08)70195-9","article-title":"Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: Results up to 4 years from a randomised, multicentre trial","author":"Mas","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arteri.2015.01.006_bib0995","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.STR.0000152333.75932.fe","article-title":"Restenosis after carotid angioplasty, stenting, or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS)","volume":"36","author":"McCabe","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.arteri.2015.01.006_bib1000","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S1474-4422(09)70227-3","article-title":"Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): Long-term follow-up of a randomised trial","author":"Bonati","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.arteri.2015.01.006_bib1005","doi-asserted-by":"crossref","unstructured":"CAVATA Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Catotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001;357:1729-37.","DOI":"10.1016\/S0140-6736(00)04893-5"},{"key":"10.1016\/j.arteri.2015.01.006_bib1010","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jvs.2007.06.045","article-title":"Long-term results of 442 consecutive, standardized carotid endarterectomy procedures in standard-risk and high-risk patients","volume":"46","author":"Flanigan","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.arteri.2015.01.006_bib1015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0912321","article-title":"Stenting versus endarterectomy for treatment of carotid-artery stenosis","volume":"363","author":"Brott","year":"2010","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"10.1016\/j.arteri.2015.01.006_bib1020","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1161\/STROKEAHA.110.595330","article-title":"The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): Stenting versus carotid endarterectomy for carotid disease","volume":"41","author":"Mantese","year":"2010","journal-title":"Stroke."},{"key":"10.1016\/j.arteri.2015.01.006_bib1025","doi-asserted-by":"crossref","unstructured":"Matsumura JS, Gray W, Chaturvedi S, Yamanouchi D, Peng L, Verta P. Results of carotid artery stenting with distal embolic protection with improved systems: Protected Carotid Artery Stenting in Patients at High Risk for Carotid Endarterectomy (PROTECT) trial. J Vasc Surg.;55:968-976.","DOI":"10.1016\/j.jvs.2011.10.120"},{"key":"10.1016\/j.arteri.2015.01.006_bib1030","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1078-5884(97)80178-5","article-title":"Local versus general anaesthesia in carotid endarterectomy: A systematic review of the evidence","volume":"3","author":"Tangkanakul","year":"1997","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.arteri.2015.01.006_bib1035","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jama.1995.03520420037035","article-title":"Endarterectomy for asymptomatic carotid artery stenosis","volume":"273","year":"1995","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2015.01.006_bib1040","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(04)16146-1","article-title":"MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group, Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial","volume":"363","author":"Halliday","year":"2004","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.arteri.2015.01.006_bib1045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000107388","article-title":"Endarterectomy, best medical treatment or both for stroke prevention in patients with symptomatic carotid artery stenosis","volume":"24","author":"Cardona","year":"2007","journal-title":"Cerebrovasc Dis."},{"key":"10.1016\/j.arteri.2015.01.006_bib1050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(13)62038-3","article-title":"Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMPPRIS): The final results of a randomised trial","volume":"383","author":"Derdeyn","year":"2014","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.arteri.2015.01.006_bib1055","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1227\/NEU.0000000000000229","article-title":"Advances and surgical considerations in the treatment of moyamoya disease","volume":"74","author":"Arias","year":"2014","journal-title":"Neurosurgery"},{"key":"10.1016\/j.arteri.2015.01.006_bib1060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10143-010-0237-x","article-title":"Patient selection for revascularization procedures in adult Moyamoya disease based on dynamic perfusion computerized tomography with acetazolamide challenge (PCTA)","volume":"33","author":"Andaluz","year":"2010","journal-title":"Neurosurg Rev."}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916815000108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916815000108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T18:20:30Z","timestamp":1566411630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916815000108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":106,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0214916815000108"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2015.01.006","relation":{},"ISSN":["0214-9168"],"issn-type":[{"value":"0214-9168","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevenci\u00f3n secundaria del ictus isqu\u00e9mico no cardioemb\u00f3lico","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2015.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}